Abstract
Gastric inhibitory polypeptide (GIP) is produced within endocrine cells of the small intestine and released into the circulation upon nutrient ingestion. This study has quantified the levels of this insulinotropic peptide in the intestines of lean and diabetic obese ob/ob mice and estimated the proportion that is glycated. The total intestinal GIP concentration and content of the diabetic mice were significantly greater (p < 0.01) than that of control animals. Affinity chromatographic separation and side-viewing GIP radioimmunoassay demonstrated that approx 20% of the GIP extracted from intestines of ob/ob mice was present in glycated form. Less than 2% of intestinal GIP was glycated in lean mice. In conclusion substantial quantities of glycated GIP exist within the intestines of diabetic ob/ob mice, suggesting that this may be a contributing factor to the physiological disarray of this syndrome.
Similar content being viewed by others
References
Morgan, L. M. (1996). Biochem. Soc. Trans. 24, 585–591.
Ebert, R. and Creutzfeldt, W. (1980). Front. Horm. Res. 7, 192–201.
Nauck, M. A., Bartels, E., Ørskov, C., Ebert, R., and Creutzfeldt, W. (1993). J. Clin. Endocrinol. Metab. 76, 912–917.
Hartmann, H., Ebert, R., and Creutzfeldt, W. (1986). Diabetologia 29, 112–114.
O’Harte, F. P. M., Gray, A. M., and Flatt, P. R. (1998). J. Endocrinol. 156, 237–243.
Yip, R. G.-C., Boylan, M. O., Kieffer, T. J., and Wolfe, M. M. (1998). Endocrinology 139, 4004–4007.
Eckel, R. H., Fujimoto, W. J., and Brunzell, J. D. (1978). Diabetes 28, 1141–1142.
Oben, J., Morgan, L., Fletcher, J., and Marks, V. (1991). J. Endocrinol. 130, 267–272.
Knapper, J. M., Puddicombe, S. M., Morgan, L. M., and Fletcher, J. M. (1995). J. Nutr. 125, 183–188.
Brownlee, M., Cerami, A., and Vlassara, H. (1988). Diabet. Metab. Res. Rev. 4, 437–451.
Brownlee, M. (1992). Diabetes 41(Suppl. 2), 57–60.
Perry, R. E., Swamy, M. S., and Abraham, E. C. (1987). Exp. Eye Res. 44, 269–282.
Lino, K., Yoshinari, M., Yamamoto, M., et al. (1996). Diabetologia 39, 800–806.
Shaklai, N., Garlick, R. L., and Bunn, H. F. (1984). J. Biol. Chem. 259, 3812–3817.
Greene, D. A., Sima, A. A. F., Stevens, M. J., Feldman, E. L., and Lattimer, S. A. (1992). Diabetes Care 15, 1902–1925.
Cullum, N. A., Mahon, J., Stringer, K., and McLean, W. G. (1991). Diabetologia 34, 387–389.
Gundberg, C. M., Anderson, M., Dickson, I., and Gallop, P. M. (1986). J. Biol. Chem. 31, 14,557–14,561.
Bookchin, R. M. and Gallop, P. M. (1968). Biochem. Biophys. Res. Commun. 32, 86–93.
Danze, P. M., Tarjoram, A., Rousseaux, J., Fossati, P., and Dautrevaux, M. (1987). Clin. Chim. Acta 166, 143–153.
Menini, T., Gugliucci, A., Sodahlon, Y. K., Stahl, A. J. C., Blickle, J. F., and Brogard, J. M. (1993). Ann. Biol. Clin. 51, 887–891.
Ganea, E. and Harding, J. J. (1994). Biochem. Soc. Trans. 22, 445S.
Takahashi, M., Lu, Y., Myint, T., Fujii, J., Wada, Y., and Taniguchi, N. (1995). Biochemistry 34, 1433–1438.
Blakytny, R. and Harding, J. J. (1992). Biochem. J. 288, 303–307.
Oda, A., Bannai, C., Yamaoka, T., Katori, T., Matsushima, T., and Yamashita, K. (1994). Horm. Metab. Res. 26, 1–4.
O’Harte, F. P. M., Abdel-Wahab, Y. H. A., Conlon, J. M., and Flatt, P. R. (1998). Diabetologia 41, 1187–1193.
Abdel-Wahab, Y. H. A., O’Harte, F. P. M., Mooney, M. H., Conlon, J. M., and Flatt, P. R. (1999). Biochim. Biophys. Acta 1452, 60–67.
O’Harte, F. P. M., Højrup, P., Barnett, C. R., and Flatt, P. R. (1996). Peptides 17, 1323–1330.
O’Harte, F. P. M., Abdel-Wahab, Y. H. A., Conlon, J. M., and Flatt, P. R. (1998). Biochim. Biophys. Acta 1425, 319–327.
Bailey, C. J. and Flatt, P. R. (1997). In: Textbook of diabetes, 2 ed. Pickup, J. and Williams, G. (eds.). Blackwell Scientific Publications: Oxford.
Halaas, J. L., Gajiwala, K. S., Maffei, M., et al. (1995). Science 269, 543–546.
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Nature 372, 425–432.
Pederson, R. A. (1994). In: Gut peptides biochemistry and physiology. Walsh, J. H. and Dockray, G. J. (eds.). Raven Press: New York.
Flatt, P. R., Bailey, C. J., Kwasowski, P., Swanston-Flatt, S. K., and Marks, V. (1983). Diabetes 32, 433–435.
Flatt, P. R., Bailey, C. J., Kwasowski, P., Page, T., and Marks, V. (1984). J. Endocrinol. 101, 249–256.
Bailey, C. J., Flatt, P. R., Kwasowski, P., Powell, C. J., and Marks, V. (1984). Acta Endocrinol. 112, 224–229.
Abdel-Wahab, Y. H. A., O’Harte, F. P. M., Ratcliff, H., McClenaghan, N. H., Barnett, C. R., and Flatt, P. R. (1996). Diabetes 45, 1489–1496.
O’Harte, F. P. M., Mooney, M. H., and Flatt, P. R. (1999). Diabetes 48, 758–765.
O’Harte, F. P. M., Mooney, M. H., Kelly, C. M. N., and Flatt, P. R. (2000). J. Endocrinol. 165, 639–648.
Mentlein, R., Gallwitz, B., and Schmidt, W. E. (1993). Eur. J. Biochem. 214, 829–835.
Kieffer, T. J., McIntosh, C. H. S., and Pederson, R. A. (1995). Endocrinology 136, 3585–3596.
Flatt, P. R. and Bailey, C. J. (1981). Diabetologia 20, 573–577.
Flatt, P. R. and Bailey, C. J. (1981). Horm. Metabol. Res. 13, 556–560.
Stevens, J. F. (1971). Clin. Chem. Acta 32, 199–201.
Morgan, L. M., Morris, B. A., and Marks, V. (1978). Ann. Clin. Biochem. 15, 172–177.
Greenwood, F. C. and Hunter, W. M. (1963). Biochemical J. 116, 357–362.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mooney, M.H., Abdel-Wahab, Y.H.A., Morgan, L.M. et al. Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice. Endocr 16, 167–171 (2001). https://doi.org/10.1385/ENDO:16:3:167
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:16:3:167